Evidence map›Paper›PMID 34718118›Full record

ArticleBiochimica et biophysica acta. Molecular basis of disease2022

SARS-CoV-2 infection negatively affects ovarian function in ART patients.

Yamila Herrero, Natalia Pascuali, Candela Velázquez, Gonzalo Oubiña, Vanesa Hauk, Ignacio de Zúñiga, Mariana Gómez Peña, Gustavo Martínez, Mariano Lavolpe, Florencia Veiga and 4 more

Open access · greenAbstract read
In one paragraph

Article in Biochimica et biophysica acta. Molecular basis of disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
10.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it, 77 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Yamila HerreroOvarian Pathophysiology Studies Laboratory, Institute of Experimental Biology and Medicine (IByME) - CONICET, Buenos Aires, Argentina.
Natalia PascualiOvarian Pathophysiology Studies Laboratory, Institute of Experimental Biology and Medicine (IByME) - CONICET, Buenos Aires, Argentina.
Candela VelázquezOvarian Pathophysiology Studies Laboratory, Institute of Experimental Biology and Medicine (IByME) - CONICET, Buenos Aires, Argentina.
Gonzalo OubiñaOvarian Pathophysiology Studies Laboratory, Institute of Experimental Biology and Medicine (IByME) - CONICET, Buenos Aires, Argentina.
Vanesa HaukImmunopharmacology Laboratory, Institute of Biological Chemistry (IQUIBICEN), School of Exact and Natural Sciences, University of Buenos Aires-CONICET, Buenos Aires, Argentina.
Ignacio de ZúñigaPregna Medicina Reproductiva, Buenos Aires, Argentina.
Mariana Gómez PeñaPregna Medicina Reproductiva, Buenos Aires, Argentina.
Gustavo MartínezMedicina Reproductiva Fertilis, Buenos Aires, Argentina.
Mariano LavolpeIn Vitro Buenos Aires, Buenos Aires, Argentina.
Florencia VeigaIVI, Buenos Aires, Argentina.
Fernando NeuspillerIVI, Buenos Aires, Argentina.
Dalhia AbramovichOvarian Pathophysiology Studies Laboratory, Institute of Experimental Biology and Medicine (IByME) - CONICET, Buenos Aires, Argentina.
Leopoldina ScottiOvarian Pathophysiology Studies Laboratory, Institute of Experimental Biology and Medicine (IByME) - CONICET, Buenos Aires, Argentina; Centro de Investigaciones y Transferencia del Noroeste de la Provincia de Buenos Aires (CITNOBA) - CONICET - UNNOBA - UNSAdA, San Antonio de Areco, Argentina.
Fernanda ParborellOvarian Pathophysiology Studies Laboratory, Institute of Experimental Biology and Medicine (IByME) - CONICET, Buenos Aires, Argentina. Electronic address: fparborell@dna.uba.ar.
Consejo Nacional de Investigaciones Científicas y Técnicas · ARFecunditas Instituto de Medicina Reproductiva · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Several organs, such as the heart, breasts, intestine, testes, and ovaries, have been reported to be target tissues of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. To date, no studies have demonstrated SARS-CoV-2 infection in the female reproductive system. In the present study, we investigated the effects of SARS-CoV-2 infection on ovarian function by comparing follicular fluid (FF) from control and recovered coronavirus disease 2019 (COVID-19) patients and by evaluating the influence of these FF on human endothelial and non-luteinized granulosa cell cultures. Our results showed that most FFs (91.3%) from screened post COVID-19 patients were positive for IgG antibodies against SARS-CoV-2. Additionally, patients with higher levels of IgG against SARS-CoV-2 had lower numbers of retrieved oocytes. While VEGF and IL-1β were significantly lower in post COVID-19 FF, IL-10 did not differ from that in control FF. Moreover, in COV434 cells stimulated with FF from post COVID-19 patients, steroidogenic acute regulatory protein (StAR), estrogen-receptor β (Erβ), and vascular endothelial growth factor (VEGF) expression were significantly decreased, whereas estrogen-receptor α (ERα) and 3β-hydroxysteroid dehydrogenase (3β-HSD) did not change. In endothelial cells stimulated with post COVID-19 FF, we observed a decrease in cell migration without changes in protein expression of certain angiogenic factors. Both cell types showed a significantly higher γH2AX expression when exposed to post COVID-19 FF. In conclusion, our results describe for the first time that the SARS-CoV-2 infection adversely affects the follicular microenvironment, thus dysregulating ovarian function.

Indexed as

Host-Pathogen InteractionsReproductive Techniques, AssistedSARS-CoV-2AdultAntibodies, ViralBiomarkersCells, CulturedCOVID-19CytokinesEnzyme-Linked Immunosorbent AssayFemaleFertilityFollicular FluidGranulosa CellsHumansImmunoglobulin GAntibodies, ViralBiomarkersCytokinesImmunoglobulin GAngiogenesisCOVID-19Follicular fluidRetrieved oocytesSARS-CoV-2 IgG antibodies

Identifiers

PMID34718118
PMCPMC8550892
OpenAlexW3209229028

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.